RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
Monocytosis
View Complete Description-
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice.
Authors: Christophe Combadière, Stéphane Potteaux, Mathieu Rodero, Tabassome Simon, Adeline Pezard, Bruno Esposito, Régine Merval, Amanda Proudfoot, Alain Tedgui, Ziad Mallat
Circulation 2008 Apr 1 -
Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
Authors: Marie-Laure Santiago-Raber, Hirofumi Amano, Eri Amano, Lucie Baudino, Masako Otani, Qingshun Lin, Falk Nimmerjahn, J Sjef Verbeek, Jeffrey V Ravetch, Yoshinari Takasaki,…
Arthritis and rheumatism 2009 Aug
Thought leaders and organizations working on research involving monocytosis.
- Eri Amano
- Marie-Laure Santiago-Raber
- Hirofumi Amano
- Shozo Izui
- Liliane Fossati-Jimack
- Masonic Cancer Center, University of Minnesota
- National Heart, Lung, and Blood Institute (NHLBI)
- Amgen
- King's College London
- Dana-Farber Cancer Institute
- University of Geneva
- Université Pierre et Marie Curie
- Imperial College London
- Mayo Clinic College of Medicine
- Keio University School of Medicine
-
Imatinib Mesylate in Treating Patients With Chronic Myelomonocytic Leukemia or Atypical Chronic Myeloid Leukemia
conditions: Leukemia
interventions: imatinib mesylate
-
Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
conditions: Juvenile Myelomonocytic Leukemia
interventions: Stem Cell Transplant
Community
